Analytical Data
-
Gene name
45931.0
- Application
-
Alternative Names
OCT1；OCT1；OTF1；POU domain. class 2. transcription factor 1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P04406
-
Expression Region
2-335aa
-
AA Sequence
GKVKVGVNGFGRIGRLVTRAAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVKAENGKLVINGNPITIFQERDPSKIKWGDAGAEYVVESTGVFTTMEKAGAHLQGGAKRVIISAPSADAPMFVMGVNHEKYDNSLKIISNASCTTNCLAPLAKVIHDNFGIVEGLMTTVHAITATQKTVDGPSGKLWRDGRGALQNIIPASTGAAKAVGKVIPELNGKLTGMAFRVPTANVSVVDLTCRLEKPAKYDDIKKVVKQASEGPLKGILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVKLISWYDNEFGYSNRVVDLMAHMASKE
-
Molecular Weight
51.9kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Recombinant protein 45931, derived from a specific gene of interest, has garnered significant attention in the field of molecular biology and biotechnology due to its potential applications in therapeutic and diagnostic processes. Research into this protein extensively began when initial studies revealed its unique structural characteristics and functional properties, which suggested its involvement in crucial biological pathways. The quest for understanding its role has been driven by the pressing need for novel biomarkers and therapeutic targets in various diseases, including cancer and autoimmune disorders. Scientists are particularly interested in the protein's interaction with cellular receptors and its influence on signal transduction mechanisms. Moreover, advancements in recombinant DNA technology have enabled the efficient production of this protein in heterologous systems, facilitating detailed investigation of its biochemical properties and biological activities. Ongoing studies aim to elucidate the protein's mechanism of action, assess its efficacy in preclinical models, and explore its potential as a platform for drug development. Overall, the research on recombinant protein 45931 represents a promising intersection of basic research and applied science, with implications for improving disease diagnosis and treatment strategies.
